These compounds may interact with:
SUMO-conjugating enzyme UBC9
Potentially involved in: cancer; animal mammary neoplasms; mammary neoplasms, experimental; atypical teratoid/rhabdoid tumor; breast cancer; glioblastoma; group 3 medulloblastoma; invasive ductal carcinoma; lung cancer; medulloblastoma, large-cell; multiple myeloma; non-small cell lung cancer; osteosarcoma; ovarian cancer; pituitary cancer; psoriasis; tuberculosis and treatment for 6 months; waldenstrons macroglobulinemia; carcinoma; mammary neoplasms, animal
Disease data sourced from Pharos.